Literature DB >> 26342292

Spontaneous clearance of HCV accompanying hepatitis after liver transplantation.

Tomomi Kogiso1, Etsuko Hashimoto2, Yuichi Ikarashi2, Kazuhisa Kodama2, Makiko Taniai2, Nobuyuki Torii2, Hiroto Egawa3, Masakazu Yamamoto3, Katsutoshi Tokushige2.   

Abstract

Re-infection by the hepatitis C virus (HCV) occurs rapidly after liver transplantation (LT), and spontaneous clearance of HCV is rare under immunosuppressive conditions. Here, we report on two patients who underwent LT to treat liver cirrhosis and hepatocellular carcinoma. The immunosuppressants prescribed were short-term corticosteroids, tacrolimus, and mycophenolate mofetil. A 50-year-old woman underwent LT, with her brother as the donor. She acquired HCV of serological type 1 after LT; the HCV RNA level was 6.0 logIU/mL. Corticosteroids were discontinued within 24 days, with a total dose of 669 mg (adjusted) prednisolone (PSL). The serum alanine aminotransferase (ALT) level increased to 700 U/L by day 55 post-LT. Surprisingly, HCV RNA was not detected on day 87. A 52-year-old man underwent LT, with his sister as the donor. He became rapidly re-infected with HCV of serological type 2; the HCV RNA level was 6.9 logIU/mL. Corticosteroids were given for 24 days, with a total dose of 827 mg (adjusted) PSL. The serum ALT level increased continuously and his HCV cleared 115 days after LT. Both donor and recipient had the major IL28B genotype. HCV was eliminated spontaneously, even under immunosuppressive conditions, after PSL discontinuation without interferon treatment. Minimal use of immunosuppressants and the presence of hepatitis may have contributed to HCV clearance. However, it is important to evaluate additional relevant cases.

Entities:  

Keywords:  IL28B polymorphism; Immunosuppressant; Liver transplantation; Spontaneous HCV clearance

Mesh:

Substances:

Year:  2015        PMID: 26342292     DOI: 10.1007/s12328-015-0602-y

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  34 in total

Review 1.  Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.

Authors:  J M Micallef; J M Kaldor; G J Dore
Journal:  J Viral Hepat       Date:  2006-01       Impact factor: 3.728

Review 2.  Immunosuppression and HCV recurrence after liver transplantation.

Authors:  Dimitrios N Samonakis; Giacomo Germani; Andrew K Burroughs
Journal:  J Hepatol       Date:  2011-09-29       Impact factor: 25.083

3.  The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection.

Authors:  Jason Grebely; Kimberly Page; Rachel Sacks-Davis; Maarten Schim van der Loeff; Thomas M Rice; Julie Bruneau; Meghan D Morris; Behzad Hajarizadeh; Janaki Amin; Andrea L Cox; Arthur Y Kim; Barbara H McGovern; Janke Schinkel; Jacob George; Naglaa H Shoukry; Georg M Lauer; Lisa Maher; Andrew R Lloyd; Margaret Hellard; Gregory J Dore; Maria Prins
Journal:  Hepatology       Date:  2013-11-22       Impact factor: 17.425

4.  Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus.

Authors:  Franziska S Hoffmann; Andreas Schmidt; Meike Dittmann Chevillotte; Christian Wisskirchen; Johannes Hellmuth; Simone Willms; Rachel H Gilmore; Jürgen Glas; Matthias Folwaczny; Tobias Müller; Thomas Berg; Ulrich Spengler; Karen Fitzmaurice; Dermot Kelleher; Nicole Reisch; Charles M Rice; Stefan Endres; Simon Rothenfusser
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

Review 5.  Natural history of hepatitis C.

Authors:  Rachel H Westbrook; Geoffrey Dusheiko
Journal:  J Hepatol       Date:  2014-11-03       Impact factor: 25.083

6.  Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus.

Authors:  Vishal Bhagat; Julie A Foont; Eugene R Schiff; Arie Regev
Journal:  Liver Transpl       Date:  2008-01       Impact factor: 5.799

7.  Long-term outcome of hepatitis C infection after liver transplantation.

Authors:  E J Gane; B C Portmann; N V Naoumov; H M Smith; J A Underhill; P T Donaldson; G Maertens; R Williams
Journal:  N Engl J Med       Date:  1996-03-28       Impact factor: 91.245

8.  Spontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression.

Authors:  Ma Somsouk; Georg M Lauer; Deborah Casson; Adam Terella; Cheryl L Day; Bruce D Walker; Raymond T Chung
Journal:  Gastroenterology       Date:  2003-06       Impact factor: 22.682

9.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

10.  Predictors of disease recurrence post living donor liver transplantation in end stage chronic HCV patients.

Authors:  Mostafa K El Awady; Noha G Bader El Din; Mahmoud Abdel Aziz Riad; Moataza H Omran; Tawfeek H Abdelhafez; Tamer Mahmoud Elbaz; Shereen Shoukry Hunter; Reham M Dawood; Ashraf O Abdel Aziz
Journal:  Dis Markers       Date:  2014-02-18       Impact factor: 3.434

View more
  4 in total

Review 1.  Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.

Authors:  George Cholankeril; Mairin Joseph-Talreja; Brandon J Perumpail; Andy Liu; Eric R Yoo; Aijaz Ahmed; Aparna Goel
Journal:  J Clin Transl Hepatol       Date:  2017-09-14

2.  Learning from a rare phenomenon - spontaneous clearance of chronic hepatitis C virus post-liver transplant: A case report.

Authors:  Noreen Singh; Mang Ma; Aldo J Montano-Loza; Rahima A Bhanji
Journal:  World J Hepatol       Date:  2022-02-27

3.  Spontaneous clearance of hepatitis C virus after liver transplantation: a report of four cases.

Authors:  Ichiro Tamaki; Toshimi Kaido; Shintaro Yagi; Yoshihide Ueda; Etsuro Hatano; Hideaki Okajima; Shinji Uemoto
Journal:  Surg Case Rep       Date:  2015-12-24

Review 4.  Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates.

Authors:  Chiranjeevi Gadiparthi; George Cholankeril; Brandon J Perumpail; Eric R Yoo; Sanjaya K Satapathy; Satheesh Nair; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.